LncRNA SNHG16 Regulates the Progress of Acute Myeloid Leukemia Through miR183-5p–FOXO1 Axis [Retraction]

Abstract

Yang R, Ma D, Wu Y, Zhang Y, Zhang L. Onco Targets Ther. 2020;13:12943–12954. At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors informed the journal that when attempting to reproduce the induction of THP-1 cells to differentiate into macrophages, it was found the THP-1 cells were still suspended, with few adhering cells and no pseudopodia or other macrophage cell forms. The cells were subsequently collected for flow analysis, and no markers of macrophages could be detected. The authors believe that the cell line used for the original experiments was contaminated. In addition, the authors have informed the journal that they cannot provide the original raw data for the reported study. As a result, the authors have determined the findings of the study are invalid and requested for the article to be retracted. The authors wish to apologise for this error. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper

Keywords

• acute myeloid leukemia
• mir-183-5p
• lncrna snhg16
• foxo1